rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Saqib Islam

Director

Company insider

Files Form 4 as: Director, ARS Pharmaceuticals; Chief Executive Officer, SpringWorks Therapeutics; Director, Passage Bio; EVP, Chief Strat & Port. Off., Alexion Pharmaceuticals.

Every Form 4 they filed

In numbers

Trades disclosed
102
Buys
1
Sells
26
Bought
$90K
Sold
$39.2M
Companies
4
Companies where not an officer
2
First trade
24 Apr 2013
Last trade
24 Jun 2026
Last filed
26 Jun 2026

Companies traded

Where they are an officer
SpringWorks TherapeuticsDirector, Officer · last 1 Jul 20250 buys · 16 sells
Alexion PharmaceuticalsOfficer · last 29 Feb 20160 buys · 10 sells
Everywhere else they filed: board seats, 10% stakes, other companies
SPRY ARS PharmaceuticalsDirector · Pharmaceuticals · last 24 Jun 20260 buys · 0 sells
PASG Passage BioDirector · Biotechnology · last 28 May 20251 buy · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
30Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
24 Jun 2026filed 26 Jun 2026SPRY ARS Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—30,000 at $0.00filing
24 Jun 2026filed 26 Jun 2026SPRY ARS Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—30,000 at $0.00filing
1 Jul 2025filed 2 Jul 2025SpringWorks Therapeuticsoption or derivativeSEC FORM 4 Code D—579,749filing
1 Jul 2025filed 2 Jul 2025SpringWorks Therapeuticsoption or derivativeSEC FORM 4 Code D—22,760filing
1 Jul 2025filed 2 Jul 2025SpringWorks Therapeuticsoption or derivativeSEC FORM 4 Code D—769,804filing
1 Jul 2025filed 2 Jul 2025SpringWorks Therapeuticsoption or derivativeSEC FORM 4 Code D—176,411filing
1 Jul 2025filed 2 Jul 2025SpringWorks Therapeuticsoption or derivativeSEC FORM 4 Code D—325,000filing
1 Jul 2025filed 2 Jul 2025SpringWorks Therapeuticsoption or derivativeSEC FORM 4 Code D—260,000filing
1 Jul 2025filed 2 Jul 2025SpringWorks Therapeuticsoption or derivativeSEC FORM 4 Code D—250,000filing
1 Jul 2025filed 2 Jul 2025SpringWorks Therapeuticsoption or derivativeSEC FORM 4 Code D—109,329filing
1 Jul 2025filed 2 Jul 2025SpringWorks TherapeuticsSEC FORM 4 Code D—954,869filing
25 Jun 2025filed 27 Jun 2025SPRY ARS Pharmaceuticalsoption or derivative · PharmaceuticalsSEC FORM 4 Code A—30,000 at $0.00filing
28 May 2025filed 30 May 2025PASG Passage Biooption or derivative · BiotechnologySEC FORM 4 Code A—201,857 at $0.00filing
3 Mar 2025filed 5 Mar 2025SpringWorks TherapeuticsSEC FORM 4 Sold$625K11,800 at $52.97filing
3 Mar 2025filed 5 Mar 2025SpringWorks TherapeuticsSEC FORM 4 Sold$1.3M23,600 at $54.24filing
3 Mar 2025filed 5 Mar 2025SpringWorks TherapeuticsSEC FORM 4 Sold$640K11,600 at $55.15filing
3 Mar 2025filed 5 Mar 2025SpringWorks TherapeuticsSEC FORM 4 Sold$79K1,400 at $56.13filing
3 Mar 2025filed 5 Mar 2025SpringWorks TherapeuticsSEC FORM 4 Sold$34K600 at $56.89filing
27 Feb 2025filed 5 Mar 2025SpringWorks TherapeuticsSEC FORM 4 Code F$1.6M30,756 at $53.41filing
20 Feb 2025filed 24 Feb 2025SpringWorks TherapeuticsSEC FORM 4 Sold$1.5M24,260 at $60.10filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1
Not placed26

Buys in green, sells in red, by the company’s sector.

Related people

Nobody else traded the same names lately.